-
Rho Expert Examines the Effect of Technology Advancements on the Future Responsibilities of Clinical Data Managers in Free Webinar
Nov 2, 2018, 10:34 AM by Michael CroftCHAPEL HILL, NC - Nov 2, 2018 - Media Advisory WHAT: Rho, a full-service contract research organization (CRO), will examine the effect of technology advancements on the future responsibilities of clinical data managers and discuss the needs introduced by the application of new technologies and broader data source availability in a new free webinar, "The Evolving Role of Clinical Data ManagementFull story -
Illumina Buys PacBio For $1.2 Billion
Nov 1, 2018, 16:15 PM by Michael CroftFull storyBio-IT World News Brief | Illumina and Pacific Biosciences today announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction. This price represents a premium of 71% to Pacific Biosciences’ 30 trading day volume weighted average share price as of the market close on October 31st, 2018, and a total enterprise value of approximately $1.2 billion on a fully diluted basis.
-
23andMe Test Cleared To Help Patients Determine How Well Drugs May Work For Them
Nov 1, 2018, 10:08 AM by Michael CroftSTAT | The genetic test is the first of its kind authorized by the Food and Drug Administration for direct-to-consumer marketing.Full story -
CRF Health, a CRF Bracket Company, sees First-in-Class eCOA Solutions Secure 15 Global Dermatology Trials
Nov 1, 2018, 09:59 AM by Michael CroftPLYMOUTH MEETING, PA - Nov 1, 2018 - CRF Health, a CRF Bracket company, the leading provider of patient-centered eSource technology solutions for the life sciences industry, today announced the awarding of two new contracts by top-20 pharma companies, which will see the companys innovative eCOA solutions used to capture patient-reported outcomes in 15 global dermatology trialsFull story -
Certara Scientists to Demonstrate Latest Modeling and Simulation Advances at AAPS PharmSci 360
Nov 1, 2018, 08:51 AM by Michael CroftPRINCETON, NJ - Nov 1, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that its scientists will lead 15 sessions, and also host a Phoenix User Group Meeting, at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting – PharmSci 360Full story -
One-Stop CAR-therapy Development Released by Creative Biolabs
Nov 1, 2018, 00:01 AM by Michael CroftSHIRLEY, NY - Nov 1, 2018 - In the field of malady treatment, cancer is always among the most obstinate diseases. The stirring development in bioscience with a new targeted therapy utilizing Full storyQIAGEN, iSpecimen, Riffyn, And More: News From October 2018
Oct 31, 2018, 12:35 PM by Michael CroftFull storyBio-IT World | October featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including QIAGEN, iSpecimen, Riffyn, and more.
Antibodies.com introduces knockout (KO) validation
Oct 31, 2018, 08:35 AM by Michael CroftMONTE SERONO, CA, UNITED STATES - Oct 31, 2018 - Antibodies are widely used in pre-clinical research to study proteins and their functions in biological pathways and diseased statesFull storyCofactor Genomics Launches ImmunoPrismTM Immune Profiling Kit, for Use in Clinical Sequencing Laboratories
Oct 30, 2018, 13:05 PM by Michael CroftSAN FRANCISCO, CA - Oct 30, 2018 - Cofactor Genomics Launches ImmunoPrismTM Immune Profiling Kit, for Use in Clinical Sequencing LaboratoriesEnables in-house, RNA-based, solid tumor profiling with powerful, cloud-based informatics tools to inform critical clinical decisionsCofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today the launch of a RNA-based immune profiling kit developed for laboratories wishing to derive the immune composition of tumor samplesFull storyHow an outsider bucked prevailing Alzheimers theory clawed for validation
Oct 29, 2018, 17:40 PM by Michael CroftSTAT | Even as potential Alzheimer's drugs failed, researchers with fresh approaches struggled to get funded and to get studies published in top journals.Full storyIBM to acquire Red Hat in deal valued at $34 billion
Oct 29, 2018, 14:41 PM by Michael CroftCNBC | The acquisition is by far IBM's largest deal ever, and third-biggest in the history of U.S. tech.Full storyOmicsLogic Fall/Winter Bioinformatics Training Program Launched by LBRN and Pine Biotech
Oct 29, 2018, 00:10 AM by Michael CroftNEW ORLEANS, LA, UNITED STATES - Oct 21, 2018 - LBRN (Louisiana Biomedical Research Network) together with Pine Biotech and the Tauber Bioinformatics Research Center from the University of Haifa, Israel have established a bioinformatics training program "OmicsLogic," a comprehensive collection of modular resources in data science and molecular biologyxFull storyDistek, Inc. Awarded U.S. Patent for Single-Use Bioreactor Design
Oct 26, 2018, 14:03 PM by Michael CroftNORTH BRUNSWICK, NJ - Oct 26, 2018 - Distek, Inc., a leading manufacturer of laboratory testing instruments for the pharmaceutical and biotechnology industry for over 40 years, has been awarded UFull storyScripps, Nvidia Tackle AI Tools, Best Practices For Genomics And Health Sensors
Oct 26, 2018, 12:30 PM by Michael CroftHPCwire | Nvidia and the Scripps Research Translational Institute announced a collaboration to develop AI and deep learning best practices, tools and infrastructure to accelerate AI applications using genomic and digital health sensor data.Full storyPhysico-chemical Characterization Platforms for Target Protein or Peptide Are Available in Creative Biolabs
Oct 26, 2018, 10:06 AM by Michael CroftSHIRLEY, IL - Oct 26, 2018 - Oct 25, 2018, as a world-leading supplier and manufacturer in the fields of antibody production and protein related projects, Creative Biolabs is always holding the faith of providing high-quality products for customers in the life science field all over the worldFull storyBioIVT Appoints Alan Findlater as Chief Commercial Officer
Oct 25, 2018, 12:58 PM by Michael CroftWESTBURY, NY - Oct 25, 2018 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has appointed Alan Findlater to the newly-created role of chief commercial officerFull storyNew Chinese Sequencer Promises 60 Human Genomes In A Day
Oct 25, 2018, 10:10 AM by Michael CroftFull storyBio- IT World News Brief | MGI Tech introduced the next iteration of its sequencer, the MGISEQ-T7, at the 13th International Conference on Genomics (ICG-13) in Shenzhen. The company also announced new library and sample prep and an application for tumor mutation detection.
Certara’s Dr. Craig Rayner Awarded 2018 Distinguished Alumni Award for the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University
Oct 24, 2018, 12:33 PM by Michael CroftPRINCETON, NJ - Oct 24, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that Craig Rayner, PharmD, MBA, senior vice president, integrated drug development with Certara Strategic Consulting, has been awarded the 2018 Distinguished Alumni Award for the Faculty of Pharmacy and Pharmaceutical Sciences at Monash UniversityFull storyAmazon Web Services Joins NIH’s STRIDES Initiative
Oct 24, 2018, 08:10 AM by Michael CroftFull storyBio-IT World News Brief | Amazon Web Services has joined NIH’s STRIDES Initiative to harness the latest cloud technologies for biomedical researchers.
Reltio Announces Record Third Quarter, Major Company Milestones, and Key Executive Additions
Oct 23, 2018, 18:28 PM by Michael CroftREDWOOD SHORES, CA - Oct 23, 2018 - Reltio, a leading provider of Modern Master Data Management and Customer 360 solutions, today announced the largest sales quarter in the companys history, a series of company milestones, new management team members, and new Board of Director and Advisory Board membersFull story